熱門資訊> 正文
LENZ Therapeutics获得Ridgeback Capital 3000万美元投资
2024-07-15 20:12
- LENZ Therapeutics (NASDAQ:LENZ) said it is looking to raise $30M through a stock purchase agreement with Ridgeback Capital Investments.
- Shares in the company were up 7% in premarket trade.
- The firm intends to use the net proceeds along with its existing cash, cash equivalents, and marketable securities, to support the regulatory, pre-commercial and potential commercial launch activities for LNZ100 as well as for working capital and general corporate purposes.
More on LENZ Therapeutics, Inc.
- LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript
- Historical earnings data for LENZ Therapeutics, Inc.
- Financial information for LENZ Therapeutics, Inc.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
